In the Angelman syndrome mouse model, Ube3am-/p+, systemic administration of IGF-2 significantly attenuated acoustically induced seizures and restored cognitive impairments assessed by measurements of contextual and recognition memories, motor deficits and working memory [247]. The gene discussed is IGF2; the disease is Angelman syndrome.